{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:08:39Z","timestamp":1789128519188,"version":"build-2803163510"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032579","name":"Beijing Medical Award Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Originally characterized as a classical mediator of analgesia, the \u03ba-opioid receptor (KOR) has recently emerged as a pivotal regulator at the crossroads of the nervous and immune systems. Beyond its canonical role in nociceptive processing, a growing body of evidence reveals that KOR exerts profound immunomodulatory effects. The receptor is broadly expressed across diverse immune cell populations, including macrophages, microglia, and lymphocytes, where it contributes to immune homeostasis by attenuating the activity of key pro-inflammatory transcription factors, notably nuclear factor \u03baB (NF-\u03baB) and signal transducer and activator of transcription 3 (STAT3). These regulatory effects are mediated through both canonical G protein\u2013coupled (G\u03b1i\/o) pathways and non-canonical \u03b2-arrestin\u2013dependent cascades. Preclinical investigations have demonstrated that pharmacological modulation of KOR confers significant therapeutic benefits in a range of immune-related disorders, including atopic dermatitis, multiple sclerosis, and osteoarthritis. However, the clinical translation of traditional KOR agonists remains limited by dose-dependent central nervous system (CNS) adverse effects, such as dysphoria and hallucinations. In this review, we synthesize recent advances in elucidating the molecular and cellular mechanisms underlying KOR-mediated immunoregulation, highlight its therapeutic potential across diverse neuroimmune pathologies, and discuss innovative pharmacological strategies, such as peripherally restricted and signaling-biased ligands-designed to preserve beneficial immunomodulatory and analgesic properties while minimizing CNS liabilities. Collectively, these insights redefine KOR as a central node in neuroimmune communication and point toward the development of next-generation precision therapeutics targeting this axis.<\/jats:p>","DOI":"10.3389\/fphar.2025.1744231","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:53:36Z","timestamp":1767768816000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["\u03ba-opioid receptor: from analgesic target to neuroimmune hub"],"prefix":"10.3389","volume":"16","author":[{"given":"Qinsi","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0165-5728(95)00159-x","article-title":"Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H","volume":"64","author":"Alicea","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"23802","DOI":"10.1074\/jbc.274.34.23802","article-title":"Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin","volume":"274","author":"Appleyard","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00109-011-0752-4","article-title":"Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo","volume":"89","author":"Aviello","year":"2011","journal-title":"J. Mol. Med. Berl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/s0022-3565(25)09680-6","article-title":"Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H","volume":"273","author":"Belkowski","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the kappa opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacol. Berl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","article-title":"Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria","volume":"27","author":"Bruchas","year":"2007","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1073\/pnas.93.15.8051","article-title":"Kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression","volume":"93","author":"Chao","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/s0028-3908(99)00063-5","article-title":"U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression","volume":"39","author":"Chao","year":"2000","journal-title":"Neuropharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0376-8716(00)00185-x","article-title":"U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages","volume":"62","author":"Chao","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"B13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev-biochem-061620-044044","article-title":"Structural insights accelerate the discovery of opioid alternatives","volume":"90","author":"Che","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12885-017-3541-9","article-title":"Down-regulation of the tumour suppressor \u03ba-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"Jama"},{"key":"B16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10753-011-9329-1","article-title":"Local kappa opioid receptor activation decreases temporomandibular joint inflammation","volume":"35","author":"Chicre-Alc\u00e2ntara","year":"2012","journal-title":"Inflammation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bja.2021.03.030","article-title":"Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma","volume":"127","author":"Connolly","year":"","journal-title":"Br. J. Anaesth."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.bja.2021.05.032","article-title":"Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysis","volume":"127","author":"Connolly","year":"","journal-title":"Br. J. Anaesth."},{"key":"B19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00002508-200305000-00005","article-title":"Sex differences in opioid analgesia: from mouse to man","volume":"19","author":"Craft","year":"2003","journal-title":"Clin. J. Pain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1744-8069-8-10","article-title":"Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3K\u03b3\/AKT\/nNOS\/NO signaling pathway","volume":"8","author":"Cunha","year":"2012","journal-title":"Mol. Pain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"837671","DOI":"10.3389\/fphar.2022.837671","article-title":"The Kappa opioid receptor: a promising therapeutic target for multiple pathologies","volume":"13","author":"Dalefield","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1234","DOI":"10.1002\/cti2.1234","article-title":"Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease","volume":"10","author":"Denny","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0167-4889(00)00107-5","article-title":"kappa-Opioid receptor potentiates apoptosis via a phospholipase C pathway in the CNE2 human epithelial tumor cell line","volume":"1499","author":"Diao","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11120","DOI":"10.1038\/ncomms11120","article-title":"Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e39841","DOI":"10.1371\/journal.pone.0039841","article-title":"Nigella sativa (black cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptors","volume":"7","author":"Duncker","year":"2012","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/s41467-023-37041-7","article-title":"Molecular mechanism of biased signaling at the kappa opioid receptor","volume":"14","author":"El Daibani","year":"2023","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jdermsci.2016.09.008","article-title":"Topical nalfurafine exhibits anti-inflammatory and anti-pruritic effects in a murine model of AD","volume":"84","author":"Elliott","year":"2016","journal-title":"J. Dermatol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/cdd.2013.152","article-title":"\u03b2-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia","volume":"21","author":"Feng","year":"2014","journal-title":"Cell Death Differ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1189\/jlb.1010546","article-title":"Transcriptional regulation of the major HIV-1 coreceptor, CXCR4, by the kappa opioid receptor","volume":"90","author":"Finley","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A phase 3 trial of difelikefalin in hemodialysis patients with Pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2012.02.006","article-title":"IFN-\u03b3 up-regulates \u03ba opioid receptors (KOR) on murine macrophage cell line J774","volume":"245","author":"Gabrilovac","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0165-5728(02)00419-8","article-title":"Enhanced humoral response in kappa-opioid receptor knockout mice","volume":"134","author":"Gav\u00e9riaux-Ruff","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1124\/jpet.103.060160","article-title":"Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells","volume":"309","author":"Gekker","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0165-5728(97)00018-0","article-title":"Inhibition of T cell superantigen responses following treatment with the kappa-opioid agonist U50,488H","volume":"75","author":"Guan","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.jaci.2023.06.023","article-title":"Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis","volume":"152","author":"Guttman-Yassky","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0006-2952(98)00162-2","article-title":"Kappa-opioid modulation of human microglial cell superoxide anion generation","volume":"56","author":"Hu","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0165-5728(95)00050-c","article-title":"Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages","volume":"60","author":"Ichinose","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"172702","DOI":"10.1016\/j.ejphar.2019.172702","article-title":"Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis","volume":"864","author":"Inan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0165-2478(02)00128-1","article-title":"Expression of functional kappa-opioid receptors on murine dendritic cells","volume":"84","author":"Kirst","year":"2002","journal-title":"Immunol. Lett."},{"key":"B41","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0143-4179(98)90052-x","article-title":"Immunomodulatory action of class mu-delta- and kappa-opioid receptor agonists in mice","volume":"32","author":"Kowalski","year":"1998","journal-title":"Neuropeptides"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1242\/jeb.062935","article-title":"Dynorphin regulates the phagocytic activity of splenic phagocytes in wall lizards: involvement of a \u03ba-opioid receptor-coupled adenylate-cyclase-cAMP-PKA pathway","volume":"214","author":"Kumar","year":"2011","journal-title":"J. Exp. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bja.2024.10.014","article-title":"Targeting the kappa opioid receptor for analgesia and antitumour effects","volume":"134","author":"Lambert","year":"2025","journal-title":"Br. J. Anaesth."},{"key":"B45","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/annrheumdis-2016-209757","article-title":"Systemic inhibition of IL-6\/Stat3 signalling protects against experimental osteoarthritis","volume":"76","author":"Latourte","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"109931","DOI":"10.1016\/j.biopha.2020.109931","article-title":"The effect of activated \u03ba-opioid receptor (\u03ba-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development","volume":"125","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/SAP.0b013e31815b9e64","article-title":"Kappa-opioid receptor agonist protects the microcirculation of skeletal muscle from ischemia reperfusion injury","volume":"61","author":"Lin","year":"2008","journal-title":"Ann. Plast. Surg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cyto.2013.01.002","article-title":"\u03ba-Opioid receptor stimulation modulates TLR4\/NF-\u03baB signaling in the rat heart subjected to ischemia-reperfusion","volume":"61","author":"Lin","year":"2013","journal-title":"Cytokine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/aps.2017.51","article-title":"Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K\/Akt signaling pathway","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"B50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12964-024-01709-4","article-title":"Activation of kappa opioid receptor suppresses post-traumatic osteoarthritis via sequestering STAT3 on the plasma membrane","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2036.2008.03730.x","article-title":"Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome","volume":"28","author":"Mangel","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1126\/science.290.5496.1574","article-title":"Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3","volume":"290","author":"McDonald","year":"2000","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/j.1471-4159.2008.05745.x","article-title":"Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways","volume":"107","author":"McLennan","year":"2008","journal-title":"J. Neurochem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1523\/JNEUROSCI.1493-16.2016","article-title":"Identification of the Kappa-Opioid receptor as a therapeutic target for oligodendrocyte remyelination","volume":"36","author":"Mei","year":"2016","journal-title":"J. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0162-3109(99)00188-5","article-title":"Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response","volume":"47","author":"Miyagi","year":"2000","journal-title":"Immunopharmacology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bja.2020.10.021","article-title":"Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer","volume":"126","author":"Montagna","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"B58","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00002826-199619050-00009","article-title":"Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain","volume":"19","author":"Pande","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.intimp.2006.01.012","article-title":"Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line","volume":"6","author":"Parkhill","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/ejp.1002","article-title":"The analgesic and anti-inflammatory effects of Salvinorin A analogue \u03b2-tetrahydropyran Salvinorin B in mice","volume":"21","author":"Paton","year":"2017","journal-title":"Eur. J. Pain"},{"key":"B61","doi-asserted-by":"publisher","first-page":"782190","DOI":"10.3389\/fneur.2021.782190","article-title":"The salvinorin analogue, Ethoxymethyl ether salvinorin B, promotes remyelination in preclinical models of multiple sclerosis","volume":"12","author":"Paton","year":"2021","journal-title":"Front. Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.biochi.2007.01.014","article-title":"The IRF family, revisited","volume":"89","author":"Paun","year":"2007","journal-title":"Biochimie"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/ar.20911","article-title":"Distribution of kappa-opioid receptor in the pulmonary artery and its changes during hypoxia","volume":"292","author":"Peng","year":"2009","journal-title":"Anat. Rec. Hob."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/s0006-2952(01)00574-3","article-title":"Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes","volume":"61","author":"Peterson","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-5728(94)00161-g","article-title":"Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of kappa opioid receptors","volume":"57","author":"Radulovi\u0107","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.biopsych.2012.06.012","article-title":"Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the \u03ba opioid agonist Salvinorin A in humans","volume":"72","author":"Ranganathan","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.lfs.2010.10.007","article-title":"Sex differences in kappa opioid pharmacology","volume":"88","author":"Rasakham","year":"2011","journal-title":"Life Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/sj.bjp.0705763","article-title":"Peripheral kappa-opioid agonists for visceral pain","volume":"141","author":"Rivi\u00e8re","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.phrs.2016.01.032","article-title":"The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation","volume":"106","author":"Rossi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0143-4179(85)90029-0","article-title":"Opiate receptor-mediated chemotaxis of human monocytes","volume":"5","author":"Ruff","year":"1985","journal-title":"Neuropeptides"},{"key":"B71","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0006-2952(02)01480-6","article-title":"U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes","volume":"65","author":"Sheng","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"115462","DOI":"10.1016\/j.biopha.2023.115462","article-title":"Activation of kappa opioid receptor (KOR) inhibits estrogen receptor (ER)-positive breast cancer through the KOR-ER-XBP1 pathway","volume":"167","author":"Shi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B74","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3724\/abbs.2023223","article-title":"\u03ba-Opioid receptor activation attenuates osteoarthritis synovitis by regulating macrophage polarization through the NF-\u03baB pathway","volume":"56","author":"Shi","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1016\/j.bja.2020.06.036","article-title":"Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia","volume":"125","author":"Silagy","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"B76","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1073\/pnas.92.15.7006","article-title":"kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system","volume":"92","author":"Simonin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B77","doi-asserted-by":"publisher","first-page":"115150","DOI":"10.1016\/j.intimp.2025.115150","article-title":"U50 488H KOR agonist reduces cartilage degradation, chondrocyte hypertrophy and bone loss in osteoarthritis","volume":"162","author":"Sinha","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2019.05.026","article-title":"Salvinorin A attenuates early brain injury through PI3K\/Akt pathway after subarachnoid hemorrhage in rat","volume":"1719","author":"Sun","year":"2019","journal-title":"Brain Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/s1567-5769(01)00083-2","article-title":"Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence","volume":"1","author":"Suzuki","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0022-3565(25)39466-8","article-title":"Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids","volume":"267","author":"Szabo","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"175214","DOI":"10.1016\/j.ejphar.2022.175214","article-title":"The role of kappa opioid receptors in immune system - an overview","volume":"933","author":"Szczepaniak","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1523\/JNEUROSCI.11-04-00928.1991","article-title":"Kappa- and delta-opioids block sympathetically dependent hyperalgesia","volume":"11","author":"Taiwo","year":"1991","journal-title":"J. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2023.06.022","article-title":"Difelikefalin suppresses itch and reduces scratching independent of inflammation in a murine model of atopic dermatitis","volume":"152","author":"Tamari","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/acs.jmedchem.8b01609","article-title":"Development of novel quinoxaline-based \u03ba-Opioid receptor agonists for the treatment of neuroinflammation","volume":"62","author":"Tangherlini","year":"2019","journal-title":"J. Med. Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1073\/pnas.88.2.360","article-title":"Immunomodulatory activity of mu- and kappa-selective opioid agonists","volume":"88","author":"Taub","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2011.10217.x","article-title":"Targeted treatment of pruritus: a look into the future","volume":"165","author":"Tey","year":"2011","journal-title":"Br. J. Dermatology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1073\/pnas.1519960113","article-title":"Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis","volume":"113","author":"Thell","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/sj.jid.5700942","article-title":"Possible roles of epidermal opioid systems in pruritus of atopic dermatitis","volume":"127","author":"Tominaga","year":"2007","journal-title":"J. Invest Dermatol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neo.2020.12.011","article-title":"Opioids drive breast cancer metastasis through the \u03b4-opioid receptor and oncogenic STAT3","volume":"23","author":"Tripolt","year":"2021","journal-title":"Neoplasia"},{"key":"B90","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0022-3565(25)33422-1","article-title":"U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist","volume":"224","author":"Vonvoigtlander","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1111\/jdv.16360","article-title":"Opioid receptors expression in the skin of haemodialysis patients suffering from uraemic pruritus","volume":"34","author":"Wieczorek","year":"2020","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cyto.2011.07.015","article-title":"U50,488H inhibits neutrophil accumulation and TNF-\u03b1 induction induced by ischemia-reperfusion in rat heart","volume":"56","author":"Wu","year":"2011","journal-title":"Cytokine"},{"key":"B93","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human \u03ba-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"106056","DOI":"10.1016\/j.intimp.2019.106056","article-title":"Naltrexone (NTX) relieves inflammation in the collagen-induced- arthritis (CIA) rat models through regulating TLR4\/NF\u03baB signaling pathway","volume":"79","author":"Xu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bja.2022.04.024","article-title":"Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort study","volume":"129","author":"Yuval","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"B96","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/etm.2020.8685","article-title":"\u03ba-opioid receptor agonists may alleviate intestinal damage in cardiopulmonary bypass rats by inhibiting the NF-\u03baB\/HIF-1\u03b1 pathway","volume":"20","author":"Zhang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"155659","DOI":"10.1016\/j.cyto.2021.155659","article-title":"Activation of \u03ba-opioid receptor inhibits inflammatory response induced by sodium palmitate in human umbilical vein endothelial cells","volume":"146","author":"Zhang","year":"2021","journal-title":"Cytokine"},{"key":"B98","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3892\/mmr.2021.12534","article-title":"Opioids in cancer: the \u03ba-opioid receptor","volume":"25","author":"Zhou","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"B99","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/164_2021_443","article-title":"Preclinical studies on Nalfurafine (TRK-820), a clinically used KOR agonist","volume":"271","author":"Zhou","year":"2022","journal-title":"Handb. Exp. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1744231\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:53:41Z","timestamp":1767768821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1744231\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":99,"alternative-id":["10.3389\/fphar.2025.1744231"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1744231","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1744231"}}